| scholarly article | Q13442814 |
| P356 | DOI | 10.1161/01.CIR.0000157156.85397.A1 |
| P698 | PubMed publication ID | 15753227 |
| P50 | author | Judith Haendeler | Q42475310 |
| Carmen Urbich | Q86379417 | ||
| Dirk Walter | Q87856645 | ||
| Florian Seeger | Q114320863 | ||
| Lothar Rössig | Q114446798 | ||
| Ulrich Rochwalsky | Q117267676 | ||
| Andreas Zeiher | Q501318 | ||
| Stefanie Dimmeler | Q110856 | ||
| P2093 | author name string | Yolande Chvatchko | |
| Anne Corbaz | |||
| Johannes Reinhold | |||
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | endothelium | Q111140 |
| P304 | page(s) | 1184-1191 | |
| P577 | publication date | 2005-03-01 | |
| P1433 | published in | Circulation | Q578091 |
| P1476 | title | p38 mitogen-activated protein kinase downregulates endothelial progenitor cells | |
| P478 | volume | 111 |
| Q44571740 | A novel vasculo-angiogenic effect of cilostazol mediated by cross-talk between multiple signalling pathways including the ERK/p38 MAPK signalling transduction cascade |
| Q33901492 | AGE-BSA down-regulates endothelial connexin43 gap junctions |
| Q53048567 | Acidic preconditioning improves the proangiogenic responses of endothelial colony forming cells. |
| Q54949873 | Acidic preconditioning of endothelial colony-forming cells (ECFC) promote vasculogenesis under proinflammatory and high glucose conditions in vitro and in vivo. |
| Q35859734 | Adiponectin and cardiovascular health: an update |
| Q34237779 | Adiponectin prevents diabetic premature senescence of endothelial progenitor cells and promotes endothelial repair by suppressing the p38 MAP kinase/p16INK4A signaling pathway. |
| Q47822223 | Advanced Glycation End-Products Downregulate HoxA9EC through Activation of Nuclear Factor Kappa B by Reciprocal Interaction. |
| Q37183949 | Aging and disease as modifiers of efficacy of cell therapy |
| Q41763265 | Altered SDF-1-mediated differentiation of bone marrow-derived endothelial progenitor cells in diabetes mellitus. |
| Q43140585 | Angiogenic-regulatory network revealed by molecular profiling heart tissue following Akt1 induction in endothelial cells |
| Q46422748 | Antioxidants increase number of progenitor endothelial cells through multiple gene expression pathways |
| Q33557210 | Atorvastatin inhibits homocysteine-induced dysfunction and apoptosis in endothelial progenitor cells |
| Q26796809 | Autologous Stem Cell Therapy: How Aging and Chronic Diseases Affect Stem and Progenitor Cells |
| Q36820225 | Biologic properties of endothelial progenitor cells and their potential for cell therapy |
| Q59340535 | Calcitonin gene-related peptide promotes proliferation and inhibits apoptosis in endothelial progenitor cells via inhibiting MAPK signaling |
| Q35070554 | Cell-based therapies for diabetic complications |
| Q79579797 | Cell-enhancement strategies for the treatment of ischemic heart disease |
| Q37859918 | Cellular and molecular mechanisms of vascular injury in diabetes--part II: cellular mechanisms and therapeutic targets |
| Q37000599 | Circulating bone marrow-derived endothelial progenitor cells: characterization, mobilization, and therapeutic considerations in malignant disease. |
| Q51897185 | Circulating endothelial progenitor cells and depression: a possible novel link between heart and soul. |
| Q36809874 | Circulating endothelial progenitor cells as a link between synovial vascularity and cardiovascular mortality in rheumatoid arthritis |
| Q37875591 | Clinical science review article: understanding the implications of diabetes on the vascular system |
| Q33550596 | Comparison of endothelial progenitor cell function in type 2 diabetes with good and poor glycemic control |
| Q38843000 | Concise Review: Perspectives and Clinical Implications of Bone Marrow and Circulating Stem Cell Defects in Diabetes. |
| Q39963297 | Defective recruitment, survival and proliferation of bone marrow-derived progenitor cells at sites of delayed diabetic wound healing in mice |
| Q36756937 | Detrimental effects of Bartonella henselae are counteracted by L-arginine and nitric oxide in human endothelial progenitor cells |
| Q63285823 | Diabetes impairs progenitor cell mobilisation after hindlimb ischaemia–reperfusion injury in rats |
| Q33410261 | Downregulation of ETS rescues diabetes-induced reduction of endothelial progenitor cells. |
| Q34006386 | Effects of lycopene on number and function of human peripheral blood endothelial progenitor cells cultivated with high glucose |
| Q89978016 | Electronegative LDL Promotes Inflammation and Triglyceride Accumulation in Macrophages |
| Q34938962 | Elevated level of pro-inflammatory eicosanoids and EPC dysfunction in diabetic patients with cardiac ischemia |
| Q36665257 | Endothelial progenitor cell dysfunction in cardiovascular diseases: role of reactive oxygen species and inflammation |
| Q88906103 | Endothelial progenitor cells and rheumatic disease modifying therapy |
| Q33572269 | Endothelial progenitor cells dysfunction and senescence: contribution to oxidative stress |
| Q36933858 | Endothelial progenitor cells for the treatment of diabetic vasculopathy: panacea or Pandora's box? |
| Q36013833 | Endothelial progenitor cells in active rheumatoid arthritis: effects of tumour necrosis factor and glucocorticoid therapy |
| Q36011477 | Endothelial progenitor cells in atherosclerosis |
| Q38001402 | Endothelial progenitor cells in diabetes mellitus. |
| Q33302128 | Endothelial progenitor cells, cardiovascular risk factors, cytokine levels and atherosclerosis--results from a large population-based study |
| Q42798882 | Endothelial progenitor cells=EPC=elemental pernicious complexity |
| Q38811965 | Extracellular histones reduce survival and angiogenic responses of late outgrowth progenitor and mature endothelial cells |
| Q36320266 | Far infra-red therapy promotes ischemia-induced angiogenesis in diabetic mice and restores high glucose-suppressed endothelial progenitor cell functions |
| Q48886329 | Globular adiponectin improves high glucose-suppressed endothelial progenitor cell function through endothelial nitric oxide synthase dependent mechanisms |
| Q38105298 | Glucose metabolism, hyperosmotic stress, and reprogramming of somatic cells. |
| Q35078469 | GroEL1, a heat shock protein 60 of Chlamydia pneumoniae, impairs neovascularization by decreasing endothelial progenitor cell function |
| Q46488605 | High glucose reduces cathepsin L activity and impairs invasion of circulating progenitor cells |
| Q37096297 | Homing and engraftment of progenitor cells: a prerequisite for cell therapy |
| Q37202006 | Inhibition of endothelial progenitor cell differentiation by VEGI. |
| Q42797849 | Inhibition of p38 MAPK facilitates ex vivo expansion of skin epithelial progenitor cells |
| Q90729475 | Insights into Endothelial Progenitor Cells: Origin, Classification, Potentials, and Prospects |
| Q36479917 | Insulin stimulates the clonogenic potential of angiogenic endothelial progenitor cells by IGF-1 receptor-dependent signaling |
| Q24629800 | Interleukin-10 deficiency impairs bone marrow-derived endothelial progenitor cell survival and function in ischemic myocardium |
| Q43089728 | Interleukin-1beta augments angiogenic responses of murine endothelial progenitor cells in vitro. |
| Q50901178 | Intrauterine growth restriction-induced deleterious adaptations in endothelial progenitor cells: possible mechanism to impair endothelial function. |
| Q37023956 | Low clonogenic potential of circulating angiogenic cells is associated with lower density of capillaries in skeletal muscle in patients with impaired glucose tolerance |
| Q36008423 | Metabolism Regulates Cellular Functions of Bone Marrow-Derived Cells used for Cardiac Therapy |
| Q41089726 | NADPH oxidase-derived overproduction of reactive oxygen species impairs postischemic neovascularization in mice with type 1 diabetes. |
| Q44937839 | Osteoprotegerin causes apoptosis of endothelial progenitor cells by induction of oxidative stress |
| Q35189234 | Ox-LDL induces dysfunction of endothelial progenitor cells via activation of NF-κB. |
| Q34446306 | Poor glycaemic control in type 2 diabetes patients reduces endothelial progenitor cell number by influencing SIRT1 signalling via platelet-activating factor receptor activation |
| Q37159185 | Premature senescence of highly proliferative endothelial progenitor cells is induced by tumor necrosis factor-alpha via the p38 mitogen-activated protein kinase pathway |
| Q37427910 | Progenitors in motion: mechanisms of mobilization of endothelial progenitor cells |
| Q35564348 | Reduced levels of circulating progenitor cells in juvenile idiopathic arthritis are counteracted by anti TNF-α therapy |
| Q21284530 | Regulation of EPCs: The Gateway to Blood Vessel Formation |
| Q38963349 | Regulation of pulmonary endothelial barrier function by kinases |
| Q36938449 | Resveratrol reduces endothelial progenitor cells senescence through augmentation of telomerase activity by Akt-dependent mechanisms |
| Q54978312 | SB202190 inhibits endothelial cell apoptosis via induction of autophagy and heme oxygenase-1. |
| Q47574529 | Signal transduction and procoagulant state of human cord blood--progenitor-derived endothelial cells after interleukin-1alpha stimulation |
| Q36599286 | Stem cell recruitment after injury: lessons for regenerative medicine |
| Q37999783 | Strategies to reverse endothelial progenitor cell dysfunction in diabetes |
| Q42139875 | TNFalpha accelerates monocyte to endothelial transdifferentiation in tumors by the induction of integrin alpha5 expression and adhesion to fibronectin |
| Q36892494 | The impact of insulin resistance on endothelial function, progenitor cells and repair |
| Q44585699 | The number and function of circulating endothelial progenitor cells in patients with Kawasaki disease |
| Q37276042 | The promise of cell-based therapies for diabetic complications: challenges and solutions |
| Q33804692 | Time course and mechanisms of circulating progenitor cell reduction in the natural history of type 2 diabetes |
| Q64105784 | Trimethylamine N-Oxide, Circulating Endothelial Progenitor Cells, and Endothelial Function in Patients with Stable Angina |
| Q30420053 | p38 mitogen-activated protein kinase (MAPK) promotes cholesterol ester accumulation in macrophages through inhibition of macroautophagy |
Search more.